Table 3.
Stool characteristics and adverse events recorded in pregnant women two weeks before the intervention and two, six, and 10 weeks after the intervention.
Weeks of Gestation | 24 | 28 | 32 | 36 | ||||
Weeks from the Start of Supplementation | −2 | 2 | 6 | 10 | ||||
Group | P | F | P | F | P | F | P | F |
n | 25 | 27 | 26 | 31 | 24 | 33 | 25 | 32 |
Stool frequency (times per day), median | 0.9 | 1.0 | 0.8 | 1.0 * | 1.1 | 1.0 | 1.2 | 1.0 |
Stool form score, mean | 3.9 | 4.2 | 3.9 | 4.2 | 3.9 | 4.0 | 3.9 | 4.3 |
Frequency of abdominal pain (days per week), median | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
frequency of diarrhea (days per week), median | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
P = Placebo-group, F = Fructooligosaccharides-group. * P < 0.05 (Mann-Whitney U test).